Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

Sponsor
Cephalon (Industry)
Overall Status
Completed
CT.gov ID
NCT00228605
Collaborator
(none)
500
38
26
13.2
0.5

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl for the potential treatment of breakthrough pain episodes in patients who have chronic noncancer pain.

Condition or Disease Intervention/Treatment Phase
  • Drug: OraVescent Fentanyl
Phase 3

Study Design

Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
An Open-Label 12 Month Study to Evaluate the Safety, Tolerability and Efficacy of OraVescent Fentanyl Citrate for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Noncancer Pain
Study Start Date :
Mar 1, 2005
Actual Study Completion Date :
May 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Safety and tolerability when used over a 12-month period for the management of breakthrough pain in opioid tolerant patients []

Secondary Outcome Measures

  1. Assess the patients' quality of life through questionnaires []

  2. Assess the patients' overall medication preferences []

  3. Assess the patients' overall medication performance []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Chronic pain diagnosis

  • Opioid tolerant

  • Has on average 1-4 breakthrough pain episodes per day

Exclusion Criteria:
  • Drug abuse history

  • Cardiopulmonary disease

  • Monoamine oxidase inhibitors (MAOIs)

  • Expected to have surgery to relieve the pain

Contacts and Locations

Locations

Site City State Country Postal Code
1 MedSearch Calera Alabama United States 35040
2 Clinical Research Consultants, Inc. Hoover Alabama United States 35216
3 Arizona Research Center Phoenix Arizona United States 85023
4 NEA Clinic Jonesboro Arkansas United States 72404
5 Lynn Institute of the Rockies Colorado Springs Colorado United States 80909
6 Radiant Research-Daytona Beach Daytona Beach Florida United States 32114
7 Advent Clinical Research Centers, Inc. St. Petersburg Florida United States 33703
8 Gold Coast Research Weston Florida United States 33331
9 Center for Prospective Outcome Studies, Inc. Atlanta Georgia United States 30327
10 Advent Clinical Research Centers, Inc. Atlanta Georgia United States 30342
11 Center for Prospective Outcome Studies, Inc. Marietta Georgia United States 30060
12 North Fulton Regional Hospital Pain Center Roswell Georgia United States 30076
13 Carmen Research Smyrna Georgia United States 30080
14 Orthopedic Health Care Boise Idaho United States 83702
15 Medisphere Medical Research Center, LLC Evansville Indiana United States 47714
16 Tri-State Arthritis & Rheumatology Center, LLC Evansville Indiana United States 47714
17 Iowa Pain Management Clinic, PC Des Moines Iowa United States 50265
18 Mid-America Physiatrists, PA Overland Park Kansas United States 66211
19 Capital Clinical Research Associates, LLC Rockville Maryland United States 20852
20 Brigham Women's Hospital, Attn: Pain Trials Center Boston Massachusetts United States 02115
21 MedVadis Research Wellesley Hills Massachusetts United States 02481-2106
22 Medex Healthcare Research Center St. Louis Missouri United States 63108
23 Radiant Research - St. Louis St. Louis Missouri United States 63141
24 Clinical Research Center of Nevada Las Vegas Nevada United States 89104
25 Northshore University Hospital Beth Page New York United States 11714
26 NYU Pain Management Center New York New York United States 10016
27 Research Across America New York New York United States 10022
28 The Lynn Health Science Institute Oklahoma City Oklahoma United States 73112
29 Southern Oregon Health & Wellness Medford Oregon United States 97504
30 Clinical Research Center of Reading, LLP West Reading Pennsylvania United States 19611
31 Healthstar Physicians Morristown Tennessee United States 37813
32 Biopharma Research Associates Sugar Land Texas United States 77479
33 Lifetree Clinical Research Salt Lake City Utah United States 84106
34 Radiant Research Salt Lake City Utah United States 84107
35 Huntsman Cancer Institute Salt Lake City Utah United States 84112
36 Pain Management Center South Burlington Vermont United States 05403
37 Northwest Clinical Research Center Bellevue Washington United States 98004
38 Rowan Research Spokane Washington United States 99207

Sponsors and Collaborators

  • Cephalon

Investigators

  • Study Director: Gwendolyn Neibler, DO, Cephalon

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00228605
Other Study ID Numbers:
  • C25608/3040/BP/US
First Posted:
Sep 29, 2005
Last Update Posted:
May 9, 2014
Last Verified:
May 1, 2014

Study Results

No Results Posted as of May 9, 2014